ATI RN
ATI Mental Health Practice A Questions
Question 1 of 5
A patient with major depressive disorder is started on venlafaxine. Which class of antidepressant does this medication belong to?
Correct Answer: D
Rationale: Venlafaxine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). SNRIs work by increasing the levels of both serotonin and norepinephrine in the brain, which helps alleviate symptoms of depression. This mechanism of action distinguishes SNRIs from other classes of antidepressants like SSRIs, TCAs, and MAOIs, making venlafaxine an effective choice for patients with major depressive disorder.
Therefore, the correct answer is D.
Choice A, SSRIs, primarily target serotonin reuptake only.
Choice B, TCAs, work by inhibiting the reuptake of norepinephrine and serotonin, but they are not as selective as SNRIs.
Choice C, MAOIs, inhibit the enzyme monoamine oxidase, leading to increased levels of various neurotransmitters, including serotonin and norepinephrine, but they are typically used as second- or third-line agents due to dietary restrictions and potential side effects.
Question 2 of 5
A patient with major depressive disorder is being treated with electroconvulsive therapy (ECT). The nurse should monitor the patient for which common side effect?
Correct Answer: A
Rationale: Memory loss, especially short-term memory loss, is a common side effect associated with electroconvulsive therapy (ECT). During ECT treatment, the electrical currents passed through the brain can disrupt short-term memory formation. This side effect is usually temporary, but patients should be closely monitored for any changes in memory function during and after the treatment.
Choices B, C, and D are incorrect because they are not commonly associated with ECT. Hypertension, weight gain, and hyperglycemia are not typically observed as side effects of ECT.
Question 3 of 5
In treating a patient with generalized anxiety disorder (GAD) using cognitive-behavioral therapy (CBT), what is the most appropriate goal of this therapy?
Correct Answer: C
Rationale: The most appropriate goal of cognitive-behavioral therapy (CBT) in treating generalized anxiety disorder (GA
D) is to change the patient's negative thought patterns. This therapy focuses on identifying and modifying distorted thinking patterns that contribute to anxiety. Exploring childhood experiences (
Choice
A) may be part of therapy, but the primary focus is on present thoughts and behaviors. While medication (
Choice
B) can help manage symptoms, CBT aims to address the root cause through cognitive restructuring. Improving social skills (
Choice
D) is not the primary goal of CBT for GAD, although it may be a secondary benefit as confidence improves with reduced anxiety.
Question 4 of 5
Which therapeutic approach is considered most effective for treating posttraumatic stress disorder (PTSD)?
Correct Answer: A
Rationale: Cognitive processing therapy is a specialized form of cognitive-behavioral therapy that has been shown to be highly effective in treating posttraumatic stress disorder (PTS
D). This therapy focuses on helping individuals process and make sense of their traumatic experiences, leading to symptom reduction and improved coping mechanisms. Psychoanalysis, medication management, and group therapy can be beneficial in some cases, but cognitive processing therapy is specifically tailored for addressing the symptoms and underlying causes of PTSD. Psychoanalysis may not be as effective for PTSD due to its focus on unconscious conflicts rather than trauma processing. Medication management can be useful as an adjunct to therapy but does not address the core issues of PTSD. Group therapy can provide support but may not offer the individualized approach that cognitive processing therapy provides.
Question 5 of 5
A patient with panic disorder is prescribed a benzodiazepine. The nurse should educate the patient that this medication is typically used for:
Correct Answer: C
Rationale: The correct answer is C: 'For short-term use due to the risk of dependence.' Benzodiazepines are usually prescribed for short-term relief of anxiety symptoms due to the risk of dependence. Prolonged use can lead to tolerance, dependence, and other adverse effects, so they are not typically used for long-term maintenance therapy (choice
A). They are not considered first-line treatments for panic disorder (choice
B) and are not primarily used to treat depression symptoms (choice
D), as their main indication is for anxiety and panic disorders.